what we’ve learned from the global response to covid-19
TRANSCRIPT
Presented by
Oct 28 2020
What wersquove learned from the global response to Covid-19
Advisory Board
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained
within the webinar are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the
content conducting the underlying research independently and objectively Advisory Board does not endorse any
company organization product or brand mentioned herein
copy 2020 Advisory Board bull All rights reserved bull advisorycom
Todayrsquos Research Experts
Christopher Kerns
Vice President
Executive Insights
KernsCadvisorycom
CD_Kerns
Vidal Seegobin
Practice Manager
International Research
Seegobivadvisorycom
seegobiv
copy 2020 Advisory Board bull All rights reserved bull advisorycom
3
1 Current as of 10272020
Most apt to compare US and EU covid performance
1
10
100
EU
Number of days since 5 daily deaths first recorded
Sweden
Italy
US
UK France
Germany
200
Source Roser M et al ldquoCoronavirus Disease (COVID-
19) ndash Statistics and Researchrdquo Our World in Data 2020
Advisory Board interviews and analysis
Daily coronavirus deaths (rolling 7-day average) per ten million people by number of days since 5 daily
deaths first recorded1
CountryTotal deaths
per million
Total cases
per million
US 682 26298
EU 371 11789
UK 663 13180
France 537 17853
Germany 121 5363
Sweden 588 10951
Italy 620 8978
copy 2020 Advisory Board bull All rights reserved bull advisorycom
4
1 Death count starts after the first 50 COVID-19 deaths in each jurisdiction and is current as of October 20 2020
Excess deaths is the difference between total deaths and expected deaths as compared to a five-year average J Wu et al ldquoTracking the True Toll of the Coronavirus Outbreakrdquo New York Times May 19 2020
Excess mortality paints more accurate picture than direct Covid-19 deaths
Excess deaths still the standard for comparing countries
Advisory Board interviews and analysis
Excess deaths and COVID deaths per jurisdiction1
All values in thousands
63
54
28
44
9 91
6 5
58
32 3135
610 9
6 5
Excess Deaths COVID Deaths
In Sweden all excess
deaths attributed to
Covid including those
in nursing homes
In the UK 91 of
excess deaths
attributed to Covid
Explanations for data discrepancies
emphasize need for caution
No universal death count methodology
Covid-19 often under- or misdiagnosed
Demographics can skew death count
bull Lack of pathologists in the US means not all
deaths at home have been tested for Covid-19
bull Doctors who make final decision may have
different thresholds for what is a Covid-19 death
bull Raw Covid-19 death count often doesnrsquot take
into account deaths caused by delayed care
bull While Belgium always counted Covid deaths in
nursing homes the UK and US didnrsquot until April
bull Singaporersquos low Covid-19 death rate is partly
due to its relatively young migrant population
copy 2020 Advisory Board bull All rights reserved bull advisorycom
5
1 Red represents complete closure yellow represents some closures green represents no mandated closures
2 Projections of 2020 GDP growth made by the International Monetary Fund
3 As of 27 October 2020
Source Rolander N ldquoSweden Says Controversial Virus Strategy Proving Effectiverdquo Bloomberg 19 April 2020 Reynolds E ldquoSweden says its coronavirus
approach has worked The numbers suggest a different storyrdquo CNN 28 April 2020 Levitz E ldquoEnding Lockdowns Wonrsquot Revive the Economyrdquo New York
Magazine 30 April 2020 ldquoIMF Country Informationrdquo IMF 2020 Roser M et al ldquoCoronavirus Disease (COVID-19) ndash Statistics and Researchrdquo Our World in
Data 2020
A number of factors mean Sweden is not an ideal comparator for most countries
In case you were wondering about Swedenhellip
Advisory Board interviews and analysis
Denmark
Schools
Finland Norway Sweden
Restaurants
and bars
Hair salons
Large
gatherings
2020 econ
outlook2
Total cases3
Deaths per
10000003
(-45) (-40) (-28) (-47)
Factors unique to Sweden
41412 14970 17908 110594
12223 6389 5146 58747
bull High willingness to self-isolate and follow governmentrsquos
recommendations without needing a clear mandate
bull Over half of households are single-person guaranteeing
moderate social distancing
bull Health care facilities not yet near reaching capacity
Benefits Drawbacks
bull Despite economic downturn
small businesses have been
able to remain open
bull Herd immunity nearly achieved
though questions remain about
strength and duration of immunity
bull Higher than average COVID
penetration particularly
compared with Scandinavia
bull Overlooked nursing homes
as at-risk locations recently
driving up mortality rate
Metrics1
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
Todayrsquos Research Experts
Christopher Kerns
Vice President
Executive Insights
KernsCadvisorycom
CD_Kerns
Vidal Seegobin
Practice Manager
International Research
Seegobivadvisorycom
seegobiv
copy 2020 Advisory Board bull All rights reserved bull advisorycom
3
1 Current as of 10272020
Most apt to compare US and EU covid performance
1
10
100
EU
Number of days since 5 daily deaths first recorded
Sweden
Italy
US
UK France
Germany
200
Source Roser M et al ldquoCoronavirus Disease (COVID-
19) ndash Statistics and Researchrdquo Our World in Data 2020
Advisory Board interviews and analysis
Daily coronavirus deaths (rolling 7-day average) per ten million people by number of days since 5 daily
deaths first recorded1
CountryTotal deaths
per million
Total cases
per million
US 682 26298
EU 371 11789
UK 663 13180
France 537 17853
Germany 121 5363
Sweden 588 10951
Italy 620 8978
copy 2020 Advisory Board bull All rights reserved bull advisorycom
4
1 Death count starts after the first 50 COVID-19 deaths in each jurisdiction and is current as of October 20 2020
Excess deaths is the difference between total deaths and expected deaths as compared to a five-year average J Wu et al ldquoTracking the True Toll of the Coronavirus Outbreakrdquo New York Times May 19 2020
Excess mortality paints more accurate picture than direct Covid-19 deaths
Excess deaths still the standard for comparing countries
Advisory Board interviews and analysis
Excess deaths and COVID deaths per jurisdiction1
All values in thousands
63
54
28
44
9 91
6 5
58
32 3135
610 9
6 5
Excess Deaths COVID Deaths
In Sweden all excess
deaths attributed to
Covid including those
in nursing homes
In the UK 91 of
excess deaths
attributed to Covid
Explanations for data discrepancies
emphasize need for caution
No universal death count methodology
Covid-19 often under- or misdiagnosed
Demographics can skew death count
bull Lack of pathologists in the US means not all
deaths at home have been tested for Covid-19
bull Doctors who make final decision may have
different thresholds for what is a Covid-19 death
bull Raw Covid-19 death count often doesnrsquot take
into account deaths caused by delayed care
bull While Belgium always counted Covid deaths in
nursing homes the UK and US didnrsquot until April
bull Singaporersquos low Covid-19 death rate is partly
due to its relatively young migrant population
copy 2020 Advisory Board bull All rights reserved bull advisorycom
5
1 Red represents complete closure yellow represents some closures green represents no mandated closures
2 Projections of 2020 GDP growth made by the International Monetary Fund
3 As of 27 October 2020
Source Rolander N ldquoSweden Says Controversial Virus Strategy Proving Effectiverdquo Bloomberg 19 April 2020 Reynolds E ldquoSweden says its coronavirus
approach has worked The numbers suggest a different storyrdquo CNN 28 April 2020 Levitz E ldquoEnding Lockdowns Wonrsquot Revive the Economyrdquo New York
Magazine 30 April 2020 ldquoIMF Country Informationrdquo IMF 2020 Roser M et al ldquoCoronavirus Disease (COVID-19) ndash Statistics and Researchrdquo Our World in
Data 2020
A number of factors mean Sweden is not an ideal comparator for most countries
In case you were wondering about Swedenhellip
Advisory Board interviews and analysis
Denmark
Schools
Finland Norway Sweden
Restaurants
and bars
Hair salons
Large
gatherings
2020 econ
outlook2
Total cases3
Deaths per
10000003
(-45) (-40) (-28) (-47)
Factors unique to Sweden
41412 14970 17908 110594
12223 6389 5146 58747
bull High willingness to self-isolate and follow governmentrsquos
recommendations without needing a clear mandate
bull Over half of households are single-person guaranteeing
moderate social distancing
bull Health care facilities not yet near reaching capacity
Benefits Drawbacks
bull Despite economic downturn
small businesses have been
able to remain open
bull Herd immunity nearly achieved
though questions remain about
strength and duration of immunity
bull Higher than average COVID
penetration particularly
compared with Scandinavia
bull Overlooked nursing homes
as at-risk locations recently
driving up mortality rate
Metrics1
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
3
1 Current as of 10272020
Most apt to compare US and EU covid performance
1
10
100
EU
Number of days since 5 daily deaths first recorded
Sweden
Italy
US
UK France
Germany
200
Source Roser M et al ldquoCoronavirus Disease (COVID-
19) ndash Statistics and Researchrdquo Our World in Data 2020
Advisory Board interviews and analysis
Daily coronavirus deaths (rolling 7-day average) per ten million people by number of days since 5 daily
deaths first recorded1
CountryTotal deaths
per million
Total cases
per million
US 682 26298
EU 371 11789
UK 663 13180
France 537 17853
Germany 121 5363
Sweden 588 10951
Italy 620 8978
copy 2020 Advisory Board bull All rights reserved bull advisorycom
4
1 Death count starts after the first 50 COVID-19 deaths in each jurisdiction and is current as of October 20 2020
Excess deaths is the difference between total deaths and expected deaths as compared to a five-year average J Wu et al ldquoTracking the True Toll of the Coronavirus Outbreakrdquo New York Times May 19 2020
Excess mortality paints more accurate picture than direct Covid-19 deaths
Excess deaths still the standard for comparing countries
Advisory Board interviews and analysis
Excess deaths and COVID deaths per jurisdiction1
All values in thousands
63
54
28
44
9 91
6 5
58
32 3135
610 9
6 5
Excess Deaths COVID Deaths
In Sweden all excess
deaths attributed to
Covid including those
in nursing homes
In the UK 91 of
excess deaths
attributed to Covid
Explanations for data discrepancies
emphasize need for caution
No universal death count methodology
Covid-19 often under- or misdiagnosed
Demographics can skew death count
bull Lack of pathologists in the US means not all
deaths at home have been tested for Covid-19
bull Doctors who make final decision may have
different thresholds for what is a Covid-19 death
bull Raw Covid-19 death count often doesnrsquot take
into account deaths caused by delayed care
bull While Belgium always counted Covid deaths in
nursing homes the UK and US didnrsquot until April
bull Singaporersquos low Covid-19 death rate is partly
due to its relatively young migrant population
copy 2020 Advisory Board bull All rights reserved bull advisorycom
5
1 Red represents complete closure yellow represents some closures green represents no mandated closures
2 Projections of 2020 GDP growth made by the International Monetary Fund
3 As of 27 October 2020
Source Rolander N ldquoSweden Says Controversial Virus Strategy Proving Effectiverdquo Bloomberg 19 April 2020 Reynolds E ldquoSweden says its coronavirus
approach has worked The numbers suggest a different storyrdquo CNN 28 April 2020 Levitz E ldquoEnding Lockdowns Wonrsquot Revive the Economyrdquo New York
Magazine 30 April 2020 ldquoIMF Country Informationrdquo IMF 2020 Roser M et al ldquoCoronavirus Disease (COVID-19) ndash Statistics and Researchrdquo Our World in
Data 2020
A number of factors mean Sweden is not an ideal comparator for most countries
In case you were wondering about Swedenhellip
Advisory Board interviews and analysis
Denmark
Schools
Finland Norway Sweden
Restaurants
and bars
Hair salons
Large
gatherings
2020 econ
outlook2
Total cases3
Deaths per
10000003
(-45) (-40) (-28) (-47)
Factors unique to Sweden
41412 14970 17908 110594
12223 6389 5146 58747
bull High willingness to self-isolate and follow governmentrsquos
recommendations without needing a clear mandate
bull Over half of households are single-person guaranteeing
moderate social distancing
bull Health care facilities not yet near reaching capacity
Benefits Drawbacks
bull Despite economic downturn
small businesses have been
able to remain open
bull Herd immunity nearly achieved
though questions remain about
strength and duration of immunity
bull Higher than average COVID
penetration particularly
compared with Scandinavia
bull Overlooked nursing homes
as at-risk locations recently
driving up mortality rate
Metrics1
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
4
1 Death count starts after the first 50 COVID-19 deaths in each jurisdiction and is current as of October 20 2020
Excess deaths is the difference between total deaths and expected deaths as compared to a five-year average J Wu et al ldquoTracking the True Toll of the Coronavirus Outbreakrdquo New York Times May 19 2020
Excess mortality paints more accurate picture than direct Covid-19 deaths
Excess deaths still the standard for comparing countries
Advisory Board interviews and analysis
Excess deaths and COVID deaths per jurisdiction1
All values in thousands
63
54
28
44
9 91
6 5
58
32 3135
610 9
6 5
Excess Deaths COVID Deaths
In Sweden all excess
deaths attributed to
Covid including those
in nursing homes
In the UK 91 of
excess deaths
attributed to Covid
Explanations for data discrepancies
emphasize need for caution
No universal death count methodology
Covid-19 often under- or misdiagnosed
Demographics can skew death count
bull Lack of pathologists in the US means not all
deaths at home have been tested for Covid-19
bull Doctors who make final decision may have
different thresholds for what is a Covid-19 death
bull Raw Covid-19 death count often doesnrsquot take
into account deaths caused by delayed care
bull While Belgium always counted Covid deaths in
nursing homes the UK and US didnrsquot until April
bull Singaporersquos low Covid-19 death rate is partly
due to its relatively young migrant population
copy 2020 Advisory Board bull All rights reserved bull advisorycom
5
1 Red represents complete closure yellow represents some closures green represents no mandated closures
2 Projections of 2020 GDP growth made by the International Monetary Fund
3 As of 27 October 2020
Source Rolander N ldquoSweden Says Controversial Virus Strategy Proving Effectiverdquo Bloomberg 19 April 2020 Reynolds E ldquoSweden says its coronavirus
approach has worked The numbers suggest a different storyrdquo CNN 28 April 2020 Levitz E ldquoEnding Lockdowns Wonrsquot Revive the Economyrdquo New York
Magazine 30 April 2020 ldquoIMF Country Informationrdquo IMF 2020 Roser M et al ldquoCoronavirus Disease (COVID-19) ndash Statistics and Researchrdquo Our World in
Data 2020
A number of factors mean Sweden is not an ideal comparator for most countries
In case you were wondering about Swedenhellip
Advisory Board interviews and analysis
Denmark
Schools
Finland Norway Sweden
Restaurants
and bars
Hair salons
Large
gatherings
2020 econ
outlook2
Total cases3
Deaths per
10000003
(-45) (-40) (-28) (-47)
Factors unique to Sweden
41412 14970 17908 110594
12223 6389 5146 58747
bull High willingness to self-isolate and follow governmentrsquos
recommendations without needing a clear mandate
bull Over half of households are single-person guaranteeing
moderate social distancing
bull Health care facilities not yet near reaching capacity
Benefits Drawbacks
bull Despite economic downturn
small businesses have been
able to remain open
bull Herd immunity nearly achieved
though questions remain about
strength and duration of immunity
bull Higher than average COVID
penetration particularly
compared with Scandinavia
bull Overlooked nursing homes
as at-risk locations recently
driving up mortality rate
Metrics1
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
5
1 Red represents complete closure yellow represents some closures green represents no mandated closures
2 Projections of 2020 GDP growth made by the International Monetary Fund
3 As of 27 October 2020
Source Rolander N ldquoSweden Says Controversial Virus Strategy Proving Effectiverdquo Bloomberg 19 April 2020 Reynolds E ldquoSweden says its coronavirus
approach has worked The numbers suggest a different storyrdquo CNN 28 April 2020 Levitz E ldquoEnding Lockdowns Wonrsquot Revive the Economyrdquo New York
Magazine 30 April 2020 ldquoIMF Country Informationrdquo IMF 2020 Roser M et al ldquoCoronavirus Disease (COVID-19) ndash Statistics and Researchrdquo Our World in
Data 2020
A number of factors mean Sweden is not an ideal comparator for most countries
In case you were wondering about Swedenhellip
Advisory Board interviews and analysis
Denmark
Schools
Finland Norway Sweden
Restaurants
and bars
Hair salons
Large
gatherings
2020 econ
outlook2
Total cases3
Deaths per
10000003
(-45) (-40) (-28) (-47)
Factors unique to Sweden
41412 14970 17908 110594
12223 6389 5146 58747
bull High willingness to self-isolate and follow governmentrsquos
recommendations without needing a clear mandate
bull Over half of households are single-person guaranteeing
moderate social distancing
bull Health care facilities not yet near reaching capacity
Benefits Drawbacks
bull Despite economic downturn
small businesses have been
able to remain open
bull Herd immunity nearly achieved
though questions remain about
strength and duration of immunity
bull Higher than average COVID
penetration particularly
compared with Scandinavia
bull Overlooked nursing homes
as at-risk locations recently
driving up mortality rate
Metrics1
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
6
1 Emergency use authorization
Source McGinley L Johnson C ldquoFDA poised to announce tougher standards for a covid-19 vaccine that make it unlikely one will be cleared by Election
Dayrdquo The Washington Post Grady D et al ldquoAstraZeneca Under Fire for Vaccine Safety Releases Trial Blueprintsrdquo The New York Times Zimmer C
Thomas K ldquoJohnson amp Johnsonrsquos Vaccine Advances Sparking Optimism in Racerdquo The New York Times Talev M ldquoAxios-Ipsos poll Vaccine resistance
growsrdquo Axios Kasinadhuni M Divack P ldquoHow to spot coronavirus misinformationmdashand keep it from spreadingrdquo Advisory Board Daily Briefing
How can we prepare now to ensure optimal outcomes
Finish line is still a vaccine
60Of US adults say it is not very
likely that they would seek out
a first-generation vaccine
COVID-19 VACCINE UPDATES HEALTH SYSTEM CHECKLIST
Manufacturers are increasing age and
race diversity in clinical trials
Pfizer Moderna and AstraZeneca
released protocols on trial analysis
Novavax and JampJ launched Phase 3
trials but the latter paused due to illness
USrsquo Operation Warp Speed plans to
include one more vaccine into its efforts
USrsquo FDA to release stricter guidance on
vaccine EUA1 process
Review available trial protocols to
understand the analysis process and final
results when they are released
Educate employees patients and
communities about the vaccine approval
and distribution process
Anticipate and prepare to respond to
misinformation and pushback
Start demand planning for distribution
including the logistics of a potential 2nd
dose and symptomsoutcomes tracking
Advisory Board research and analysis
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
8
Global vaccine access key to eradicating pandemic
A global approach to equitable vaccine distribution
1 US National Academies of Sciences Engineering and Medicine
Source ldquoBoost for global response to COVID-19 as economies worldwide formally sign up to COVAX facilityrdquo WHO 21 September 2020 Max Garland ldquoCOVID-19 vaccine
distribution will put FedExrsquos cold chain to the testrdquo Commercial Appeal 27 September 2020 Melanie Stark ldquoCOVID vaccine the biggest supply chain challenge in modern
historyrdquo MHD Supply Chain 28 August 2020 Nidhi Subbaraman ldquoWho gets a COVID vaccine first Access plans are taking shaperdquo Nature 17 September 2020
The world takes steps to prepare for vaccine
The Australian Government secures 100 million
syringes and sets up air freight agreement by
mid-summer to safeguard imports
FedEx ramps up digitally-tracked cold chain
capacity with contingencies to reduce wastage
NASEM1 provides risk-based framework to
allocate vaccine to US residents
WHO-Gavi COVAX
bull COVAX guarantees participating countries
will receive the same number of vaccines
proportional to their populations at the
same cost
bull In the agreement 3 of every countryrsquos
population receives the vaccine initially with
health and social care workers receiving
first doses
bull Once this threshold is reached vaccine will
be sent equally to all countries until 20 of
their populations are vaccinated
bull The remaining 80 will receive the vaccine
depending on how urgently constituent
countries need it
150+ countries signed up to WHO-Gavi COVAX
facility ndash but not the US
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
9
2031
60
26
78
2924
3621 24
Canada France Germany Italy Japan Netherlands Spain Switzerland UK US
916
756798 789 755 753
654 640
907820
1 In-patient
Source ldquoHealth Care Resourcesrdquo Organization for
Economic Co-Operation and Development April 2020
Many public systems run high bed occupancy and long length of stay
In February we worried about bed capacity
Advisory Board interviews and analysis
Number of acute care
beds in the US in 1992
962301
Number of acute care
beds in the US in 2016
789197
DATA SPOTLIGHT
68 99 89 78 282 108 73 81 69 61
Average length of stay
Beds per 1000 people Occupancy rate
Inpatient beds per capita average occupancy and average length of stay by country
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
10
Available beds in province prior to outbreak 906 357 356
Total additional beds made available +9349 +2077 +2075
Beds occupied by Covid-19 patients1 -910 -243 -193
Net increase in available beds1 in
province ( increase in parentheses)
+9345
(+1032)
+2191
(+482)
+2238
(+483)
1 As of 14 April 2020
2 In February 2020 England has 4122 critical care beds
Source ldquoOntario Health Sector A Preliminary Review of the Impact of the Covid-19 Outbreak on Hospital Capacityrdquo Financial
Accountability Office of Ontario 28 April 2020 Igmen A ldquoHow Italian hospitals added 800 ICU beds in 2 weeks in response to the
pandemicrdquo Advisory Board 20 March 2020 West D ldquoNHS hospitals have four times more empty beds than normalrdquo HSJ 13 April 2020
After Italy many learned to expand bed capacity quickly
Advisory Board interviews and analysis
Government responses yielded unprecedented increases in acute and critical bed supply availability
DATA SPOTLIGHT
Critical beds Italy added
in two weeks by halting
electives and converting
semi-intensive care beds
800
Critical care beds in
Londonrsquos NHS Nightingale
field hospital which doubled
Englandrsquos total critical care
bed supply in just 10 days2
4000
Measures taken in Ontario Canada
between 15 March and 14 April
Acute
beds
Critical
care beds
Critical care
beds wvent
Hospital efforts to free up existing capacity
(including canceling elective surgeries)+6849 +585 +583
Moving hospital patients to other locations +1000 0 0
Newly funded beds +1500 +500 0
Other expansion of critical care capacity 0 +992 0
Additional ventilator deployment 0 0 +1492
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
11
Considerations when preparing for a second wave
Scenario
planning
Community
messaging
Cohorting
sites
Capacity
management
Staffing and
support
Chronic disease
management
PPE and supply
chain management
bull Dedicating hospitals or
other facilities to Covid
bull Constructing an
external site
bull Consumer survey
findings
bull Communication guide
bull Leading indicators
bull Coronavirus scenario
planning
bull Elective surgery
scenario modeling
bull Staffing for the surge
bull Picklist of emotional
support options
bull Working with your local
government
bull Triaging and testing protocols
in the ED during Flu season
bull Handling a PPE shortage
bull Reevaluating supply
chain and procurement
practices
bull Resources for adapting
chronic care delivery
bull Digital strategies for
patient engagement
bull 7 ways to maximize revenue
capture amid Covid-19
bull Leading
service rationalization decisions
Avoiding a cash
crunch
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
12
1 National Centre for Infectious Disease
2 Command Control CommunicationsSource Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic Experiences from the unit at the epicentre
of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
Tan Tock Seng Hospital learns from previous outbreaks to design new site
Into ldquowave 2rdquo most will run ldquohotrdquo and ldquocoldrdquo tracks
Tan Tock Seng Hospital (TTSH)
1700 beds Designated Covid-19 Hospital bull Singapore
bull Previously designated as Singaporersquos hospital for
2003 SARS and 2009 H1N1 outbreaks
bull TTSH established a 330-bed facility for infectious
diseases NCID1 opening in late 2019
bull Main hospital supports NCID with resources
workforce and transfer of patients
bull During Covid-19 scaled up to 586+ beds and
reduced ambulatory services to lt50 to free up
staff
CASE EXAMPLE
Artificial Intelligence Bed Management
System (AIBMU)
Provides TTSH with decision support for allocating
beds The system uses 345 rules to define the
best place for a patient based on priority
Operations Command Centre (OCC)
Uses C32 system to track real-time location of
Covid-19 patients using analytics to distribute
resources and manage patient flow
NCID
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
13
Tan Tock Seng places premium on projecting and flexing to demand
Central command shifts visibility from ldquostockrdquo to ldquoflowrdquo
Admission Bed Allocation
Discharge
Tracking Discharge
Resource
Planning
AIBMU Decision SupportDATA SPOTLIGHT
Operating capacity of
TTSHrsquos ED during first
wave of pandemic
80
Maximum admin staff
needed per shift to run the
AIBMU responsible for
1700 beds
3
OCC uses C3 system to track Covid patient preventing nosocomial spread
Source Dr Eugene Fidelis Soh ldquoSmart Hospital for the Futurerdquo HealthManagement Volume 20 Issue 3 2020 Rasappan et al ldquoA surgeonrsquos role in fighting a medical pandemic
Experiences from the unit at the epicentre of COVID-19 in Singapore ndash A cohort perspectiverdquo International Journal of Surgery 16 May 2020 Lin R et al ldquoFrom SARS to COVID-19 the
Singapore journeyrdquo The Medical Journal of Australia 6 April 2020
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
16
Source ldquoGlobal Influenza Surveillance and Response System (GISRS)rdquo WHO 2020
Proactive flu vaccinations and Covid-19 prevention measures stifle flu outbreaks
Southern countries experience record low influenza rates
Advisory Board interviews and analysis
Weekly influenza cases in select countries across the Southern Hemisphere
Past five years (2016-2020)
0
400
800
1200
1 26 51
Argentina
Weeks
2020
2016
2017
20192018
0
50
100
150
200
1 26 51
South Africa
Weeks
2020
20192018
2017 2016
0
400
800
1200
1 26 51
Australia
Weeks
2020
2019 2017
2016
2018
0
175
350
525
700
1 26 51
Chile
2020
2019
2018
2017
2019
Weeks
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
copy 2020 Advisory Board bull All rights reserved bull advisorycom
17
Source Hoffman J ldquoFearing a lsquoTwindemicrsquo Health Experts Push Urgently for Flu Shotsrdquo New York Times 12 October 2020 ldquoHow To Increase Flu
Vaccination During The COVID-19 Pandemic Health Affairs Blog 6 August 2020 ldquoPromoting Vaccination in the Workplacerdquo CDC 27 August 2020
Organisations overcoming common vaccination campaign roadblocks
Opportunity for providers to increase flu vaccination numbers
Move vaccination
efforts away from
clinics by enlisting
community partners
such as churches
pharmacies and stores
Create a culture of
immunization by
conducting a strong
culturally-sensitive
and transparent
vaccination campaign
within the community
Incentivise the public
by reducing cost
providing vouchers or
refreshments or
relating vaccination
targets to a business
goal for employers
Covid-19 contamination
is an ever-present
threat causing public
reluctance to re-engage
with elective care
Misinformation and
fear-based messaging
presents barriers to
vaccination efforts
Loss of income or
insurance restricts
access to vaccine and
accountability to get
vaccine is limited
Barriers to
vaccination
campaign
success
Moves
you can
make
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
LEGAL CAVEAT
Advisory Board has made efforts to verify the accuracy of the information it provides to members This report relies on data obtained from many sources however and
Advisory Board cannot guarantee the accuracy of the information provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal
medical accounting or other professional advice and its reports should not be construed as professional advice In particular members should not rely on any legal
commentary in this report as a basis for action or assume that any tactics described herein would be permitted by applicable law or appropriate for a given memberrsquos situation
Members are advised to consult with appropriate professionals concerning legal medical tax or accounting issues before implementing any of these tactics Neither Advisory
Board nor its officers directors trustees employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this report
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or graded ranking by Advisory Board or (c)
failure of member and its employees and agents to abide by the terms set forth herein
Advisory Board and the ldquoArdquo logo are registered trademarks of The Advisory Board Company in the United States and other countries Members are not permitted to use these
trademarks or any other trademark product name service name trade name and logo of Advisory Board without prior written consent of Advisory Board All other
trademarks product names service names trade names and logos used within these pages are the property of their respective holders Use of other company trademarks
product names service names trade names and logos or images of the same does not necessarily constitute (a) an endorsement by such company of Advisory Board and its
products and services or (b) an endorsement of the company or its products or services by Advisory Board Advisory Board is not affiliated with any such company
IMPORTANT Please read the following
Advisory Board has prepared this report for the exclusive use of its members Each member acknowledges and agrees that this report and the information contained herein
(collectively the ldquoReportrdquo) are confidential and proprietary to Advisory Board By accepting delivery of this Report each member agrees to abide by the terms as stated herein
including the following
1 Advisory Board owns all right title and interest in and to this Report Except as stated herein no right license permission or interest of any kind in this Report is intended
to be given transferred to or acquired by a member Each member is authorized to use this Report only to the extent expressly authorized herein
2 Each member shall not sell license republish or post online or otherwise this Report in part or in whole Each member shall not disseminate or permit the use of and shall
take reasonable precautions to prevent such dissemination or use of this Report by (a) any of its employees and agents (except as stated below) or (b) any third party
3 Each member may make this Report available solely to those of its employees and agents who (a) are registered for the workshop or membership program of which this
Report is a part (b) require access to this Report in order to learn from the information described herein and (c) agree not to disclose this Report to other employees or
agents or any third party Each member shall use and shall ensure that its employees and agents use this Report for its internal use only Each member may make a
limited number of copies solely as adequate for use by its employees and agents in accordance with the terms herein
4 Each member shall not remove from this Report any confidential markings copyright notices andor other similar indicia herein
5 Each member is responsible for any breach of its obligations as stated herein by any of its employees or agents
6 If a member is unwilling to abide by any of the foregoing obligations then such member shall promptly return this Report and all copies thereof to Advisory Board
18copy 2020 Advisory Board bull All rights reserved bull advisorycom
This webinar is sponsored by Medtronic for educational purposes only The content views and opinions contained within the webinar
are copyrighted by Advisory Board and all rights are reserved Advisory Board experts wrote the content conducting the underlying
research independently and objectively Advisory Board does not endorse any company organization product or brand mentioned
herein
This slide deck should be used for educational purposes only Advisory Board has made efforts to verify the accuracy of the information
contained herein Advisory Board relies on data obtained from many sources and cannot guarantee the accuracy of the information
provided or any analysis based thereon In addition Advisory Board is not in the business of giving legal medical accounting or other
professional advice and its slide decks should not be construed as professional advice In particular readers should not rely on any
legal commentary in this slide deck as a basis for action or assume that any tactics described herein would be permitted by applicable
law or appropriate for a given readers situation Readers are advised to consult with appropriate professionals concerning legal
medical tax or accounting issues before implementing any of these tactics Neither Advisory Board nor its officers directors trustees
employees and agents shall be liable for any claims liabilities or expenses relating to (a) any errors or omissions in this slide deck
whether caused by Advisory Board or any of its employees or agents or sources or other third parties (b) any recommendation or
graded ranking by Advisory Board or (c) failure of reader and its employees and agents to abide by the terms set forth herein
Medtronic has obtained distribution rights to this content for the purpose of customer education It is the policy of Advisory Board to
enforce its intellectual property rights to the fullest extent permitted under law The entire content of this slide deck including any images
or text is copyrighted and may not be distributed modified reused or otherwise used except as provided herein without the express
written permission of Advisory Board The use or misuse of the Advisory Board trademarks copyrights or other materials except as
permitted herein is expressly prohibited and may be in violation of copyright law trademark law communications regulations and
statutes and other laws statutes andor regulations
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom
655 New York Avenue NW Washington DC 20001
202-266-5600 advisorycom